We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Feedback Plc | LSE:FDBK | London | Ordinary Share | GB00BJN59X09 | ORD 50P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 1.00 | 2.82% | 36.50 | 6,959 | 15:36:53 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 35.00 | 38.00 | 36.50 | 35.50 | 35.50 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Electronic Computers | 1.03M | -2.92M | -0.2188 | -1.67 | 4.73M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 15:36:46 | O | 6,000 | 37.00 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 19/9/2024 | 16:51 | ALNC |  Feedback inks collaboration deal to streamline NHS referrals |
| 19/9/2024 | 07:00 | UK RNS | Feedback PLC Collaboration Agreement |
| 02/9/2024 | 07:00 | UK RNS | Feedback PLC Further funding to extend NHS Trust pathways |
| 10/7/2024 | 12:07 | ALNC | Feedback partnership to boost offering and commercial opportunities |
| 10/7/2024 | 07:00 | UK RNS | Feedback PLC Vertex In Healthcare Collaboration |
| 01/7/2024 | 11:09 | ALNC | TRADING UPDATES: Rainbow Rare and Ecora strike Phalaborwa deal |
| 01/7/2024 | 07:00 | UK RNS | Feedback PLC CDC Contract Awarded by Queen Victoria Hospital |
| 28/6/2024 | 07:00 | UK RNS | Feedback PLC Change of Name of Nominated Adviser and Broker |
| 22/5/2024 | 17:28 | ALNC | EARNINGS AND TRADING: Adnams toasts increase in sales but loss widens |
| 22/5/2024 | 07:00 | UK RNS | Feedback PLC Trading Update |
Feedback (FDBK) Share Charts1 Year Feedback Chart |
|
1 Month Feedback Chart |
Intraday Feedback Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 11/10/2024 | 19:45 | FEEDBACK plc Medical Imaging Technology | 11,497 |
| 04/11/2019 | 07:39 | Feedback | 35 |
| 01/11/2018 | 15:33 | ****Feedback PLC**** | 3,006 |
| 03/2/2010 | 11:50 | Feedback looks interesting - could easily be a ten bagger over next year | 396 |
| 03/9/2002 | 11:53 | ainsley long .........................quick shart it | 2 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 14:36:46 | 37.00 | 6,000 | 2,220.00 | O |
| 13:20:00 | 36.55 | 259 | 94.66 | O |
| 12:22:22 | 35.90 | 700 | 251.30 | O |
| Top Posts |
|---|
Posted at 11/10/2024 09:20 by Feedback Daily Update Feedback Plc is listed in the Electronic Computers sector of the London Stock Exchange with ticker FDBK. The last closing price for Feedback was 35.50p.Feedback currently has 13,334,659 shares in issue. The market capitalisation of Feedback is £4,867,151. Feedback has a price to earnings ratio (PE ratio) of -1.67. This morning FDBK shares opened at 35.50p |
Posted at 20/9/2024 17:14 by ducatiman Ditto Ged.Just so glad I reduced significantly. What price the next placing? |
Posted at 20/9/2024 13:22 by ged5 This fella is very good at putting out announcements that might be believable if he answered all questions in presentaions and was actually a shareholder.India partnership "likely initially" UK, UAE, SA partnership "Resell each other's products" Do FDBK sell much? Unknown partner "intention to explore creating a solution" "The parties intend to pilot the solution" All these maybes - could be a play! Beginning to doubt my sanity at actually owning some shares in this lot. |
Posted at 12/9/2024 17:39 by pugugly Could this be the salvation for FDBK?"Keir Starmer vows to face down ‘loud opposition’ to fix NHS Prime minister promises 10-year plan after Darzi report concludes health service in a ‘critical condition’" |
Posted at 01/8/2024 14:07 by digger2779 Some brave soul just bought 1 share or is it a precursor to news? |
Posted at 10/7/2024 16:13 by pugugly Ged5 - Thanks for that - A 100 share company Shares of £1. but do not appear to have been paid. Creditors of some £63771. (Accounts to 31st May) |
Posted at 10/7/2024 11:59 by ged5 Well that announcement contained a surprise for me but perhaps it shouldn't have done so."As part of the Agreement, Vertex will licence the database capabilities of Feedback's legacy picture archiving communication system Cadran PACS, now with the MedDream Viewer, which will allow it to build a PACS proposition that will initially be sold in South Africa and other international markets including the UK, where it sells PACS. This is another example of the Company's strategy to generate licencing royalties from its legacy products." I seem to remember FDBK saying they were moving away from PACS because of the growth opportunities and competition. Still, I guess they're only licencing the software. "Cadran is Feedback's established Picture Archiving and Communications System (PACS) which facilitates the review of medical imaging studies by clinicians. It is a progressive and rigorously tested Class 1 medical device with a longstanding legacy of service at NHS institutions, such as the Royal Papworth Hospital. However, it is currently positioned in a competitive market that shows little opportunity for future growth." 10th July 2019 Not really paying too much attention but I've only just noticed the description of FDBK:- Started out in 2021 as the specialist medical imaging technology company Became the specialist clinical communication company later in that year after the launch of Carelocker. The following year it became the frontline clinical technology company but went back to the specialist clinical communication company a few months later. In May 2023 it became the clinical infrastructure specialists and has stayed up to today. Been here on and off far too long considering it's a company not too sure of its direction. Probably keep a few just in case it does stumble onto something that will bring success. Anyone know what's happening with Axial 3d, Quest or CVS? |
Posted at 28/5/2024 18:17 by ydderf LR2 you had some questions and made assertions about Nimble in the other place. This below should help you with your worries:"Imaging Biometrics, LLC data security statement (2024-05-28): Imaging Biometrics (IB) and its developed software applications (apps) comply with the requirements of the US HIPAA and the EU GDPR regulations. IB applies the principles outlined in the US FDA cybersecurity guidance to all the software apps it develops, whether or not a given app is technically classified as a medical device. IB is evaluating the changes in the newly-released revision 3 of the US NIST share price 800-171r3 standard for integration into its policies, procedures, and software development process. Similarly, IB is pursuing implementation of the recommendations contained in the NIST share price 800-218 secure software development framework and ISO 27001 information security standards. Note IB does not host the data accessed via IB Nimble. All data is hosted by the implementing client institution within its data center and is also subject to the institution’s privacy and information security policies and practices." You're welcome! Perhaps you share with the LSE posters you engaged with recently? You were commenting upon this RNS: |
Posted at 16/5/2024 13:21 by ducatiman They were going to reply after speaking to Fdbk. That tells you all you need to know. |
Posted at 12/4/2024 11:55 by hamidahamida What has feedback produced continuously since its listing many years ago?-:-MORE SHARES -:-If you look at the companies de-listing from AIM, they have been listed for few years are still high cash burn businesses who will need to raise more money. Their share prices are a fraction of where they were when they listed...Are investors we really going to miss them? Companies who have used AIM to raise money to grow and become profitable will not delist. How long do you give a company before it starts generating money? Surely few years is enough?AIM has a reputation for eroding shareholder value, but this is largely down to companies at the bottom end, that will never produce anything apart from more shares. To improve this perception we need more of the low quality companies to delist so higher quality businesses remain. The types of business that can give investors a positive return on their investment, at least within few years.This will help AIM change its reputation, for the better, and attract more investment & liquidity. |
Posted at 15/11/2022 16:25 by chopper harris1 What the hell wwre they thinking of with the 200:1 consolidation?10:1?, yes, possibly, if they wanted to make some kind of statement which might have taken the FDBK share price a little out of typical penny share territory in the eyes of some. But 200:1? Sheer bloody madness which has almost certainly given most of us very little chance of ever getting our money back. Which clowns gave our hapless FDBK chumps this advice? |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
